Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Unibios HoldingsATH:BIOSK -1.66%62 Equity-to-Asset is 0.51 as of Dec. 2025, which is 2% below its 10-year median of 0.52. GuruFocus rates ATH:BIOSK with a GF Score™ of 62/100 and a GF Value™ of €1.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 3,084 Industrial Products companies, Unibios Holdings ranks worse than 57.72% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Unibios Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €18.68 Mil. Unibios Holdings's Total Assets for the quarter that ended in Dec. 2025 was €36.78 Mil.
Therefore, Unibios Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.51.
The historical rank and industry rank for Unibios Holdings's Equity-to-Asset or its related term are showing as below:
ATH:BIOSK'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.4 Med: 0.52 Max: 0.6
Current: 0.51
During the past 13 years, the highest Equity to Asset Ratio of Unibios Holdings was 0.60. The lowest was 0.40. And the median was 0.52.
ATH:BIOSK's Equity-to-Asset is ranked worse than 57.72% of 3084
companies
in the Industrial Products industry
Industry Median: 0.56
vs ATH:BIOSK: 0.51
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Unibios Holdings Equity-to-Asset Related Terms
Unibios Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Unibios Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ATH:BIOSK vs VLTO, ZWS, CECO: Equity-to-Asset Comparison
For the Pollution & Treatment Controls subindustry, Unibios Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unibios Holdings Equity-to-Asset vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Unibios Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Unibios Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Unibios Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unibios Holdings (ATH:BIOSK) has a Equity-to-Asset of 0.51 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Unibios Holdings and its competitors. This is near median its historical median of 0.52. Over the past decade, Unibios Holdings' Equity-to-Asset has ranged from 0.40 to 0.60. According to the industry distribution chart, Unibios Holdings ranks #1780 out of 3084 companies in the Industrial Products industry, placing it in the top 57.7%.
Is Unibios Holdings' Equity-to-Asset too high?
Unibios Holdings' current Equity-to-Asset of 0.51 is near median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 0.60. The Industrial Products industry median Equity-to-Asset is 0.56. Unibios Holdings' value of 0.51 is 8.9% below this industry median. Based on the distribution chart, Unibios Holdings ranks #1780 out of 3084 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Unibios Holdings has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' Equity-to-Asset compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Unibios Holdings ranks #1780 out of 3084 companies for Equity-to-Asset. This places Unibios Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.56. Unibios Holdings' value of 0.51 is 8.9% below this benchmark. Historically, Unibios Holdings' own Equity-to-Asset has ranged from 0.40 to 0.60 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 0.56, Unibios Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Industrial Products company?
The median Equity-to-Asset among Industrial Products companies is 0.56, based on 3,084 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Unibios Holdings's current Equity-to-Asset of 0.51 is 8.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Unibios Holdings and its competitors. For the Industrial Products industry, the median Equity-to-Asset is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Unibios Holdings's current Equity-to-Asset is 0.51, which is near median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.48, compared to a current price of €2.67 — trading 80.4% above its estimated fair value. The current Equity-to-Asset is 0.51, which is near median its 10-year median of 0.52 and 8.9% below the Industrial Products industry median of 0.56. Unibios Holdings' overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current Equity-to-Asset is 0.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?
Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued.
The current stock price of €2.67 is trading 80.4% above its estimated GF Value™ of €1.48.
GuruFocus considers Unibios Holdings to be Significantly Overvalued.
Key valuation signals for ATH:BIOSK:
Equity-to-Asset: 0.51 (near median its 10-year median of 0.52)
GF Value™: €1.48 vs. price of €2.67 (80.4% above fair value)
Industry Position: 8.9% below the Industrial Products median (#1780 of 3084)
No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
62GF Score
Get the complete analysis for ATH:BIOSK
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATH:BIOSK has been successfully added to your 
